Escalade (ESCA) Q3 2024 earnings summary

Executive summary

• Q3 2024 net sales declined 7.7% year-over-year to $67.7M due to soft consumer demand and inventory destocking, partially offset by growth in archery, safety, and basketball categories; gross margin expanded modestly despite $1.8M–$2.3M in non-recurring business rationalization expenses.

• Net income for Q3 2024 was $5.7M ($0.40 per diluted share), up from $4.3M in Q3 2023, aided by a $3.9M gain from the sale of the Mexico facility.

• Operational footprint reduced by 20% through facility sales, cost rationalization, and business consolidation, with most optimization to be completed by year-end.

• Generated $10.5M in operating cash flow, distributed over $2M in dividends, made capital expenditures, and repaid nearly $14M in debt, reducing net leverage to 1.1x.

• SG&A expenses increased 5.5% year-over-year in Q3 2024, reaching $11.7M.

Financial highlights

• Q3 2024 net income was $5.7M ($0.40 per diluted share) on net sales of $67.7M; EBITDA increased by $2M to $9.9M compared to the prior year.

• Gross margin was 24.8%, up 10 basis points year-over-year, with adjusted gross margin at 27.4% excluding non-recurring expenses.

• Operating income for Q3 2024 was $8.0M, up from $6.4M in Q3 2023.

• Recognized a $3.9M gain on the sale of the Rosarito, Mexico facility.

• Cash and cash equivalents at September 30, 2024: $426,000, down from $0.9M a year ago.

Outlook and guidance

• Expect higher gross margins through year-end and into 2025, despite continued near-term softness in consumer demand and increased promotional activity during the holiday season.

• Ongoing cost rationalization and asset divestitures are expected to drive sustained margin improvement into 2025.

• Direct-to-consumer e-commerce volumes grew 29% year-over-year in the quarter; international sales grew over 13%.

• Monitoring macroeconomic factors, including interest rates and consumer sentiment, with no expectation of materially stronger demand in the near term.

• Results for the period are not necessarily indicative of full-year 2024 performance.